세계의 항체 탐색 시장 보고서(2025년)

Antibody Discovery Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

항체 탐색 시장 규모는 향후 몇 년동안 급성장할 것으로 예상되며, 2029년까지 CAGR 10.3%로 146억 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장 배경에는 항체 신약개발 서비스 및 플랫폼에 대한 수요 증가, 신기술 개발을 위한 자금 조달의 급증, 정밀치료에 대한 수요 증가, 전통적인 치료적 역할을 넘어선 항체의 활용 범위 확대 등이 있습니다. 예측 기간의 주요 동향으로는 연구개발 활동의 활성화, 단클론항체 수요 증가, 첨단 기술 채택 확대, 표적치료제 수요 증가, 신규 항체 포맷 개발 등을 꼽을 수 있습니다.

항체 탐색 시장은 개인 맞춤형 치료제로 알려진 정밀치료제에 대한 수요 증가로 인해 크게 성장할 것으로 예상됩니다. 이 접근법은 환자 개개인의 특성에 맞는 치료를 통해 치료 효과를 높이는 것입니다. 항체 탐색은 질병 관련 분자 및 세포와 정확하게 상호작용하는 단클론 항체와 같은 표적 치료제의 개발을 촉진함으로써 정밀치료에 있어 매우 중요한 역할을 하고 있습니다. 주목할 만한 점은 2023년 1월 미국 식품의약국(FDA) 의약품평가연구센터(CDER)가 37개의 신규 분자 화합물(NME)을 승인하면서 치료용 NME의 약 34%가 개인맞춤형 의약품으로 분류되었습니다는 점입니다. 이는 항체 발굴 시장의 성장을 견인하는 정밀치료제의 매우 중요한 역할을 뒷받침하고 있습니다.

항체 탐색 시장의 주요 기업들은 항체 개발 프로세스를 간소화하고 강화하기 위해 첨단 기술에 투자하고 있습니다. 주목할 만한 혁신 중 하나는 인공지능과 계산 기술을 활용하여 항체 식별과 최적화를 가속화하는 AI 기반 계산 항체 신약개발 플랫폼의 출현입니다. 예를 들어, 2023년 10월 Swift Pharma BV는 AI 기반 항체 탐색 플랫폼을 발표했습니다. 이 플랫폼은 인공지능, 빅데이터, 머신러닝, 파지 디스플레이 기술을 통합하여 고특이성 및 고친화도 항체-항원 결합을 신속하게 예측합니다. 자연어 처리를 모방한 이 접근법은 다양한 항체 변형을 생성하여 전례 없는 효율로 종합적인 항체 라이브러리 제작을 가능하게 합니다. 이 첨단 시스템을 통해 항체 의약품 개발이 크게 가속화될 것으로 기대됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나19와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 항체 탐색 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 항체 탐색 시장 : 성장률 분석
• 세계의 항체 탐색 시장 실적 : 규모와 성장, 2019-2024
• 세계의 항체 탐색 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 항체 탐색 전체 시장(TAM)

제6장 시장 세분화

• 세계의 항체 탐색 시장 : 방법별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 파지 디스플레이
• 하이브리드종
• 기타 방법
• 세계의 항체 탐색 시장 : 항체 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 인간화 항체
• 인간 항체
• 키메라 항체
• 마우스 항체
• 세계의 항체 탐색 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 제약 및 바이오테크놀러지 업계
• 연구실
• 학술 연구실
• 세계의 항체 탐색 시장 : 파지 디스플레이별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 선택 및 스크리닝 방법
• 최적화 방법
• 세계의 항체 탐색 시장 : 하이브리드종별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 단일클론항체 생산
• 심사 및 전형 프로세스
• 세계의 항체 탐색 시장 : 기타 방법별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Transgenic Mouse Technology
• B-Cell Engineering
• Single-Cell Sorting Techniques

제7장 지역별/국가별 분석

• 세계의 항체 탐색 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 항체 탐색 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 항체 탐색 시장 : 경쟁 구도
• 항체 탐색 시장 : 기업 개요
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• WuXi Biologics
• Genmab A/S
• Evotec
• Cambrex corporation
• ChemPartner
• Aragen life science pvt ltd
• Genscript Technology Corporation
• Biocytogen
• Alcami corporation.Inc
• Twist Bioscience
• BioDuro-Sundia
• Fairjourney Biologics S.A
• Harbour BioMed
• Rockland Immunochemicals
• Creative Biolabs

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 항체 탐색 시장(2029년) : 새로운 기회를 제공하는 국가
• 항체 탐색 시장(2029년) : 새로운 기회를 제공하는 부문
• 항체 탐색 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Antibody discovery is the process of identifying and developing antibodies, which are proteins generated by the immune system to defend the body against harmful substances such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a vital role in the immune response by recognizing and binding to specific molecules known as antigens.

The primary methods employed in antibody discovery include phage display, hybridoma, and others. Phage display is a molecular biology technique utilized for the study and selection of peptides or proteins, typically antibodies, that exhibit high affinity to a target of interest. This method is widely applied in antibody discovery to generate and select antibodies with specific binding properties. Various types of antibodies, including humanized antibodies, human antibodies, chimeric antibodies, and murine antibodies, find application among end users in the pharmaceutical and biotechnology industries, research laboratories, and academic institutions.

The antibody discovery research report is one of a series of new reports from The Business Research Company that provides antibody discovery market statistics, including the antibody discovery industry's global market size, regional shares, competitors with an Antibody discovery market share, detailed antibody discovery market segments, market trends and opportunities, and any further data you may need to thrive in the antibody discovery industry. This antibody discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antibody discovery market size has grown rapidly in recent years. It will grow from $8.96 billion in 2024 to $9.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to surge in investment for drug discovery, growing investment in research and development activities, and presence of various healthcare research centers and academic institutions.

The antibody discovery market size is expected to see rapid growth in the next few years. It will grow to $14.6 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for antibody drug discovery services and platforms, surge in funding for the development of novel technologies, growing demand for precision therapeutics, and broadening the utilization of antibodies beyond their conventional therapeutic roles. Major trends in the forecast period include increased research and development activities, growing demand for monoclonal antibodies, increased adoption of advanced technologies, growing demand for targeted therapeutics, and development of novel antibody formats.

The antibody discovery market is poised for significant growth due to the increasing demand for precision therapeutics, also known as personalized therapeutics. This approach tailors medical treatments to individual patient characteristics, enhancing effectiveness. Antibody discovery plays a pivotal role in precision therapeutics by facilitating the development of targeted therapies such as monoclonal antibodies, which interact precisely with disease-related molecules or cells. Notably, in January 2023, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% of therapeutic NMEs classified as personalized medicines. This underscores the pivotal role of precision therapeutics in driving the antibody discovery market's growth.

Leading players in the antibody discovery market are investing in cutting-edge technologies to streamline and enhance antibody development processes. One notable innovation is the emergence of AI-based computational antibody drug discovery platforms, which leverage artificial intelligence and computational techniques to expedite antibody identification and optimization. For example, in October 2023, SwiftPharma BV introduced an AI-driven antibody discovery platform. This platform integrates artificial intelligence, big data, machine learning, and phage display techniques to swiftly predict high-specificity and high-affinity antibody-antigen binding. By mimicking natural language processing, this approach generates diverse antibody variations, enabling comprehensive antibody library creation with unprecedented efficiency. This advanced system significantly accelerates the discovery of potential antibody drugs.

In July 2024, Pentixapharm, a Germany-based biotech company specializing in radiopharmaceuticals, acquired Glycotope's target discovery unit for an undisclosed sum. This acquisition supports Pentixapharm's strategy to enhance its oncology pipeline by converting preclinical antibodies targeting various cancer indications into radiopharmaceuticals. In addition to the preclinical assets, Pentixapharm acquired Glycotope's laboratories, cell banks, tumor target database, and equipment, thereby further enriching its Intellectual Property portfolio beyond the CXCR4 receptor. Glycotope, also based in Germany, is a biotechnology firm focused on developing glyco-optimized antibodies for cancer immunotherapies.

Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibody discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antibody discovery market includes revenues earned by entities by providing services such as antigen identification, immunization, antibody generation, screening, and characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The antibody discovery market also includes sales of antibody libraries, phage display kits, antigen proteins, and antibody screening platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibody Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibody discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibody discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibody discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Methods: Phage Display; Hybridoma; Other Methods
• 2) By Antibody Type: Humanized Antibody; Human Antibody; Chimeric Antibody; Murine Antibody
• 3) By End Users: Pharmaceutical And Biotechnology Industry; Research Laboratory; Academic Laboratory
• Subsegments:
• 1) By Phage Display: Selection And Screening Techniques; Optimization Methods
• 2) By Hybridoma: Monoclonal Antibody Production; Screening And Selection Processes
• 3) By Other Methods: Transgenic Mouse Technology; B-Cell Engineering; Single-Cell Sorting Techniques
• Companies Mentioned: Danaher Corporation; Eurofins Scientific; Sartorius AG; Charles River Laboratories; Bruker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antibody Discovery Market Characteristics

3. Antibody Discovery Market Trends And Strategies

4. Antibody Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Antibody Discovery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antibody Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antibody Discovery Market Growth Rate Analysis
• 5.4. Global Antibody Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antibody Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antibody Discovery Total Addressable Market (TAM)

6. Antibody Discovery Market Segmentation

• 6.1. Global Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phage Display
• Hybridoma
• Other Methods
• 6.2. Global Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Humanized Antibody
• Human Antibody
• Chimeric Antibody
• Murine Antibody
• 6.3. Global Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Industry
• Research Laboratory
• Academic Laboratory
• 6.4. Global Antibody Discovery Market, Sub-Segmentation Of Phage Display, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selection And Screening Techniques
• Optimization Methods
• 6.5. Global Antibody Discovery Market, Sub-Segmentation Of Hybridoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibody Production
• Screening And Selection Processes
• 6.6. Global Antibody Discovery Market, Sub-Segmentation Of Other Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transgenic Mouse Technology
• B-Cell Engineering
• Single-Cell Sorting Techniques

7. Antibody Discovery Market Regional And Country Analysis

• 7.1. Global Antibody Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antibody Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antibody Discovery Market

• 8.1. Asia-Pacific Antibody Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antibody Discovery Market

• 9.1. China Antibody Discovery Market Overview
• 9.2. China Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antibody Discovery Market

• 10.1. India Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antibody Discovery Market

• 11.1. Japan Antibody Discovery Market Overview
• 11.2. Japan Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antibody Discovery Market

• 12.1. Australia Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antibody Discovery Market

• 13.1. Indonesia Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antibody Discovery Market

• 14.1. South Korea Antibody Discovery Market Overview
• 14.2. South Korea Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antibody Discovery Market

• 15.1. Western Europe Antibody Discovery Market Overview
• 15.2. Western Europe Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antibody Discovery Market

• 16.1. UK Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antibody Discovery Market

• 17.1. Germany Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antibody Discovery Market

• 18.1. France Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antibody Discovery Market

• 19.1. Italy Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antibody Discovery Market

• 20.1. Spain Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antibody Discovery Market

• 21.1. Eastern Europe Antibody Discovery Market Overview
• 21.2. Eastern Europe Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antibody Discovery Market

• 22.1. Russia Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antibody Discovery Market

• 23.1. North America Antibody Discovery Market Overview
• 23.2. North America Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antibody Discovery Market

• 24.1. USA Antibody Discovery Market Overview
• 24.2. USA Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antibody Discovery Market

• 25.1. Canada Antibody Discovery Market Overview
• 25.2. Canada Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antibody Discovery Market

• 26.1. South America Antibody Discovery Market Overview
• 26.2. South America Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antibody Discovery Market

• 27.1. Brazil Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antibody Discovery Market

• 28.1. Middle East Antibody Discovery Market Overview
• 28.2. Middle East Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antibody Discovery Market

• 29.1. Africa Antibody Discovery Market Overview
• 29.2. Africa Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antibody Discovery Market Competitive Landscape And Company Profiles

• 30.1. Antibody Discovery Market Competitive Landscape
• 30.2. Antibody Discovery Market Company Profiles
  • 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Antibody Discovery Market Other Major And Innovative Companies

• 31.1. WuXi Biologics
• 31.2. Genmab A/S
• 31.3. Evotec
• 31.4. Cambrex corporation
• 31.5. ChemPartner
• 31.6. Aragen life science pvt ltd
• 31.7. Genscript Technology Corporation
• 31.8. Biocytogen
• 31.9. Alcami corporation.Inc
• 31.10. Twist Bioscience
• 31.11. BioDuro-Sundia
• 31.12. Fairjourney Biologics S.A
• 31.13. Harbour BioMed
• 31.14. Rockland Immunochemicals
• 31.15. Creative Biolabs

32. Global Antibody Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibody Discovery Market

34. Recent Developments In The Antibody Discovery Market

35. Antibody Discovery Market High Potential Countries, Segments and Strategies

• 35.1 Antibody Discovery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antibody Discovery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antibody Discovery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료